达沙替尼诱发的狼疮。 - Suppr

Suppr

超能文献

Dasatinib-induced lupus.

作者信息

Rea Delphine, Bergeron Anne, Fieschi Claire, Bengoufa Djaouida, Oksenhendler Eric, Dombret Hervé

出版信息

Lancet. 2008 Aug 30;372(9640):713-4. doi: 10.1016/S0140-6736(08)61295-7.

DOI:10.1016/S0140-6736(08)61295-7

PMID:18761212

Abstract

摘要

相似文献

Dasatinib-induced lupus.

Lancet. 2008 Aug 30;372(9640):713-4. doi: 10.1016/S0140-6736(08)61295-7.

Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.

Leukemia. 2008 Nov;22(11):2127-8. doi: 10.1038/leu.2008.106. Epub 2008 May 8.

Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.

Dasatinib (Sprycel) for CML and Ph + ALL.

Med Lett Drugs Ther. 2007 Jan 15;49(1252):6-7.

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:233. doi: 10.5152/tjg.2014.5281.

Dasatinib: for some difficult cases of adult leukaemia.

Prescrire Int. 2008 Aug;17(96):149-50.

Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.

Arch Gynecol Obstet. 2011 Jan;283(1):133-4. doi: 10.1007/s00404-010-1501-6. Epub 2010 May 15.

New drugs: paliperidone, dasatinib, and decitabine.

J Am Pharm Assoc (2003). 2007 Mar-Apr;47(2):298-302. doi: 10.1331/J520-X177-5587-6556.

[Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia].

Ugeskr Laeger. 2008 Jan 28;170(5):331-3.

Dasatinib in chronic myelogenous leukemia.

N Engl J Med. 2006 Sep 7;355(10):1062; author reply 1063-4. doi: 10.1056/NEJMc061882.

引用本文的文献

Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia.

JAAD Case Rep. 2024 Sep 1;53:60-62. doi: 10.1016/j.jdcr.2024.08.020. eCollection 2024 Nov.

[Research progress in toxicology of molecular targeted anticancer drugs].

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Sep;44(5):473-8. doi: 10.3785/j.issn.1008-9292.2015.09.01.

Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling.

Oncotarget. 2015 Mar 20;6(8):6203-17. doi: 10.18632/oncotarget.3357.

Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs.

Genome Med. 2014 Aug 17;6(7):52. doi: 10.1186/s13073-014-0052-z. eCollection 2014.

ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.

Int J Hematol. 2014 Dec;100(6):611-4. doi: 10.1007/s12185-014-1666-z. Epub 2014 Sep 12.

Development of Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia during Treatment with Nilotinib.

Hematol Rep. 2014 Jun 19;6(2):5288. doi: 10.4081/hr.2014.5288. eCollection 2014 Apr 22.

Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML.

Clin Med Insights Oncol. 2011;5:185-99. doi: 10.4137/CMO.S6416. Epub 2011 Jun 23.

Metabolism considerations for kinase inhibitors in cancer treatment.

Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1175-93. doi: 10.1517/17425255.2010.506873.

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib.

Onco Targets Ther. 2009 Feb 18;2:83-94. doi: 10.2147/ott.s3971.

Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.

Drug Metab Dispos. 2009 Jun;37(6):1242-50. doi: 10.1124/dmd.108.025932. Epub 2009 Mar 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验